Active	Status	Sponsor type	Region	Phase	Filter
3 Active 11 Inactive 14 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Friesen, Craig A
NCT05480761: 7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels	Recruiting	4	1100	US	Sucraid (sacrosidase) Oral Solution 8500 IU/mL, Sucraid, Sacrosidase	QOL Medical, LLC	Congenital Sucrase-Isomaltase Deficiency, CSID, Sucrase Isomaltase Deficiency	08/24	12/24
NCT05643534: Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years	Recruiting	3	180	US	Tenapanor 50 MG, Tenapanor 25 mg bid, Placebo	Ardelyx	Irritable Bowel Syndrome With Constipation (IBS-C)	12/25	12/25
Ketotifen, NCT02484248: for Children with Functional Dyspepsia in Association with Duodenal Eosinophilia	Active, not recruiting	3	40	US	Ketotifen, Placebo	Children's Mercy Hospital Kansas City	Functional Dyspepsia	03/25	03/25
Neilan, Nancy A
No trials found